"It's been a huge ongoing debate," says Prof Horby. Scientists are trialling other steroids, such as methylprednisolone, in coronavirus patients with some promising early results.

This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...

Patients with moderate COVID-19, those with respiratory distress ... AIIMS and ICMR recommend giving 0.5 to 1 mg/kg of methylprednisolone, which is usually used to treat severe allergic reactions ...